A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Clinical trial NCT03067129 · COMPLETED
Trial details
- NCT number
- NCT03067129
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2020-05-21
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.